References

The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease

10.1016/j.kint.2016.12.029 · 2017 · External reference

Parathyroid hormone metabolism and signaling in health and chronic kidney disease

10.1016/j.kint.2016.06.041 · 2016 · External reference

Association between CKD-MBD and mortality in older patients with advanced CKD-results from the EQUAL study

10.1093/ndt/gfad100 · 2023 · External reference

Momentum toward patient outcome trials in chronic kidney disease-mineral bone disorder

10.1097/mnh.0000000000001087 · 2025 · External reference

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis

10.1056/nejmoa1205624 · 2012 · External reference

Higher versus lower phosphate targets for patients undergoing in-center hemodialysis: a randomized controlled trial

10.1681/asn.0000000765 · 2025 · External reference

Cardiovascular disease in chronic kidney disease

10.1093/eurheartj/ehaf167 · 2025 · External reference

C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients

10.2215/cjn.00710111 · 2011 · External reference

IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial

10.1038/s41591-024-03043-1 · 2024 · External reference

Chronic kidney disease-mineral and bone disorder: conclusions from a Kidney Disease: improving Global Outcomes (KDIGO) Controversies Conference

10.1016/j.kint.2024.11.013 · 2025 · External reference

Calcification score evaluation in patients listed for renal transplantation

10.1111/ctr.12888 · 2017 · External reference

Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes

10.1038/s41591-020-1116-9 · 2021 · External reference

Clustering rules: a comparison of partitioning and hierarchical clustering algorithms

10.1007/s10852-005-9022-1 · 2006 · External reference

Cluster-wise assessment of cluster stability

10.1016/j.csda.2006.11.025 · 2007 · External reference

Detecting high-risk chronic kidney disease-mineral bone disorder phenotypes among patients on dialysis: a historical cohort study

2018 · External reference

Effect of etelcalcetide vs placebo on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: two randomized clinical trials

10.1001/jama.2016.19456 · 2017 · External reference

Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients

10.1681/asn.2007090971 · 2008 · External reference

Biomarkers of bone turnover identify subsets of chronic kidney disease patients at higher risk for fracture

10.1210/clinem/dgaa317 · 2020 · External reference

Medial arterial calcification in ageing and disease: current evidence and knowledge gaps

10.1093/eurheartj/ehaf341 · 2025 · External reference

One-year romosozumab treatment followed by one-year denosumab treatment for osteoporosis in patients on hemodialysis: an observational study

2023 · External reference

Serum osteoprotegerin in prevalent hemodialysis patients: associations with mortality, atherosclerosis and cardiac function

10.1186/s12882-017-0701-8 · 2017 · External reference

The combination of malnutrition-inflammation and functional status limitations is associated with mortality in hemodialysis patients

10.1038/s41598-020-80716-0 · 2021 · External reference

Pathophysiology of chronic kidney disease-mineral bone disorder (CKD-MBD): from adaptive to maladaptive mineral homeostasis

10.1093/ckj/sfae431 · 2025 · External reference

Inflammation and gut dysbiosis as drivers of CKD-MBD

10.1038/s41581-023-00736-7 · 2023 · External reference

Bone turnover markers in the management of CKD-associated osteoporosis – a European consensus

10.1093/ndt/gfag033 · 2026 · External reference

Fish-oil supplementation and cardiovascular events in patients receiving hemodialysis

10.1056/nejmoa2513032 · 2025 · External reference